Boxer Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-250,000
| Closed | -$20.9M | – | 91 |
|
|
2021
Q2 | $20.9M | Hold |
250,000
| – | – | 0.74% | 40 |
|
|
2021
Q1 | $18.9M | Hold |
250,000
| – | – | 0.64% | 45 |
|
|
2020
Q4 | $21.9M | Hold |
250,000
| – | – | 0.7% | 40 |
|
|
2020
Q3 | $19M | Hold |
250,000
| – | – | 0.66% | 38 |
|
|
2020
Q2 | $30.8M | Hold |
250,000
| – | – | 1.36% | 28 |
|
|
2020
Q1 | $21.1M | Hold |
250,000
| – | – | 1.44% | 22 |
|
|
2019
Q4 | $21.1M | Sell |
250,000
-200,000
| -44% | -$16.9M | 1.2% | 24 |
|
|
2019
Q3 | $30.3M | Buy |
+450,000
| New | +$30.3M | 2.2% | 17 |
|
|
2016
Q4 | – | Sell |
-100,000
| Closed | -$9.25M | – | 28 |
|
|
2016
Q3 | $9.25M | Buy |
100,000
+30,000
| +43% | +$2.78M | 4.15% | 9 |
|
|
2016
Q2 | $5.45M | Hold |
70,000
| – | – | 4.83% | 10 |
|
|
2016
Q1 | $5.77M | Buy |
+70,000
| New | +$5.77M | 5.65% | 8 |
|